| Product Code: ETC7644954 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antithrombotic Drugs Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antithrombotic Drugs Market - Industry Life Cycle |
3.4 Israel Antithrombotic Drugs Market - Porter's Five Forces |
3.5 Israel Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Israel Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Israel Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Israel Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Antithrombotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Israel |
4.2.2 Growing geriatric population in Israel |
4.2.3 Rising awareness about the importance of antithrombotic drugs in preventing blood clots |
4.3 Market Restraints |
4.3.1 Stringent government regulations for drug approvals in Israel |
4.3.2 High costs associated with antithrombotic drugs |
4.3.3 Potential side effects and risks associated with long-term use of antithrombotic drugs |
5 Israel Antithrombotic Drugs Market Trends |
6 Israel Antithrombotic Drugs Market, By Types |
6.1 Israel Antithrombotic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F |
6.1.4 Israel Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F |
6.1.5 Israel Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F |
6.1.6 Israel Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.1.7 Israel Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F |
6.1.8 Israel Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F |
6.2 Israel Antithrombotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Israel Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F |
6.2.3 Israel Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F |
6.2.4 Israel Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.2.5 Israel Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Antithrombotic Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Israel Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.3.3 Israel Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Israel Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F |
6.3.5 Israel Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F |
6.3.6 Israel Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Antithrombotic Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Israel Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Israel Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Antithrombotic Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Israel Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Israel Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Antithrombotic Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Israel Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Israel Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Israel Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Antithrombotic Drugs Market Import-Export Trade Statistics |
7.1 Israel Antithrombotic Drugs Market Export to Major Countries |
7.2 Israel Antithrombotic Drugs Market Imports from Major Countries |
8 Israel Antithrombotic Drugs Market Key Performance Indicators |
8.1 Number of prescriptions of antithrombotic drugs by healthcare providers |
8.2 Patient adherence rate to antithrombotic drug therapy |
8.3 Rate of hospitalizations due to thrombotic events in Israel |
9 Israel Antithrombotic Drugs Market - Opportunity Assessment |
9.1 Israel Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Israel Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Israel Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Israel Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Antithrombotic Drugs Market - Competitive Landscape |
10.1 Israel Antithrombotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Israel Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here